Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose of S-ketamine, remifentanil and lidocaine for relieving propofol injection pain across age groups
ChiCTR2100048951Phase 4Not yet recruiting
- Sponsor
- Zhongshan Boai Hospital
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine, remifentanil, lidocaine and propofol in procedural pain (3 arms), sponsored by Zhongshan Boai Hospital. Primary endpoint: Pain score during or after propofol injection. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
esketamineremifentanillidocainepropofol
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2100048951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048951.